Novavax announced that the phase one study of its covid-19 vaccine yielded promising results. For its part, Moderna reported the estimated price of its vaccine, and Johnson & Johnson reached an agreement with the United States for 100 million doses of its vaccine in development. This is the race to find a vaccine against the new coronavirus. READ : Good news in the fight against the coronavirus: possible treatments, vaccines and findings
This is the race for the covid-19 vaccine
2020-08-05T21:46:19.499Z
Novavax announced that the phase one study of its covid-19 vaccine yielded promising results. For its part, Moderna reported the estimated price of its vaccine, and Johnson & Johnson ...